Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comirnaty after Vaxzevria (CombiVacS)
NCT05378191Phase 2Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by Hospital La Paz Institute for Health Research. Status: unknown.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05378191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378191.